3101.T

Toyobo Co., Ltd. [3101.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

3101.T Stock Summary

Earnings have grown 6.44% per last year.

Earnings are expected to fall -100% next year

Profit margins (-0.02%) are lower than the previous year (-0%)

3101.T has less than 1 year of cash runway

Debt-to-Equity ratio of 1.21 is considered moderate, deeper research suggested.

Top 10 Correlated ETFs

3101.T

Top 10 Correlated Stocks

3101.T

In the News

3101.T Financial details

Company Rating

Neutral

Market Cap

100.52B

Income

-8.84B

Revenue

408.51B

Book val./share

2145.83

Cash/share

316.84

Dividend

Dividend %

3.72%

Employees

10.89K

Optionable

Shortable

Yes

Earnings

09 May 2024

P/E

-9.9

Forward P/E

PEG

0.59

P/S

0.24

P/B

0.5

P/C

3.45

P/FCF

Quick Ratio

0.63

Current Ratio

1.47

Debt / Equity

1.21

LT Debt / Equity

0.61

EPS (TTM)

-99.47

EPS next Y

EPS next Q

EPS this Y

-105.09%

EPS next Y

EPS next 5Y

EPS last 5Y

1.65%

Revenue last 5Y

3.5%

Revenue Q/Q

5.42%

EPS Q/Q

-117.38%

SMA20

-0.8%

SMA50

2.28%

SMA100

9.57%

Inst Own

Inst Trans

ROA

-2%

ROE

-5%

ROC

0.01%

Gross Margin

20%

Oper. Margin

Profit Margin

-2%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

980.0-1182.0

52W High

-7.53%

52W Low

+11.53%

RSI

Rel Volume

1.09

Avg Volume

339.34K

Volume

369K

Perf Week

-1.53%

Perf Month

-1.26%

Perf Quarter

8.54%

Perf Half Y

7.95%

Beta

0.588

Volatility

20.69%, 20.72%

Prev Close

-1.8%

Price

1093

Change

-5.37%

3101.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	3.79K	3.82K	3.8K	4.23K	4.5K
Net income per share	-6.79	155.12	47.3	144.75	-7.37
Operating cash flow per share	88.3	498.4	394.31	192.37	87.73
Free cash flow per share	-184.72	150.88	84.8	-135.19	-352.82
Cash per share	152.61	200.48	307.91	203.77	576.87
Book value per share	1.99K	2K	2.09K	2.19K	2.13K
Tangible book value per share	2K	2K	2.07K	2.17K	2.44K
Share holders equity per share	1.99K	2K	2.09K	2.19K	2.13K
Interest debt per share	1.85K	1.95K	2.07K	2.13K	2.55K
Market cap	129.25B	101.49B	126.5B	97.14B	92.35B
Enterprise value	270.25B	247.63B	274.72B	257.66B	256.81B
P/E ratio	-214.34	7.37	30.1	7.55	-140.99
Price to sales ratio	0.38	0.3	0.37	0.26	0.23
POCF ratio	16.49	2.29	3.61	5.68	11.84
PFCF ratio	-7.88	7.58	16.79	-8.09	-2.94
P/B Ratio	0.73	0.57	0.68	0.5	0.49
PTB ratio	0.73	0.57	0.68	0.5	0.49
EV to sales	0.8	0.73	0.81	0.69	0.64
Enterprise value over EBITDA	7.74	6.91	6.75	5.82	9.61
EV to operating cash flow	34.48	5.6	7.84	15.07	32.93
EV to free cash flow	-16.48	18.48	36.47	-21.44	-8.19
Earnings yield	0	0.14	0.03	0.13	-0.01
Free cash flow yield	-0.13	0.13	0.06	-0.12	-0.34
Debt to equity	0.92	0.96	0.98	0.96	1.19
Debt to assets	0.35	0.35	0.37	0.36	0.38
Net debt to EBITDA	4.04	4.08	3.64	3.63	6.16
Current ratio	1.47	1.69	1.62	1.63	1.48
Interest coverage	16.65	16.65	20.78	23.48	7.58
Income quality	76.84	2.24	6.28	1.16	12.74
Dividend Yield	0.03	0.03	0.03	0.04	0.04
Payout ratio	-5.89	0.26	0.84	0.28	-5.43
Sales general and administrative to revenue	0.11	0.11	0.12	0.11	0.12
Research and developement to revenue	0.03	0.03	0.04	0.04	0.04
Intangibles to total assets	0.01	0.01	0.01	0.01	0.01
Capex to operating cash flow	-3.09	-0.7	-0.78	-1.7	-5.02
Capex to revenue	-0.07	-0.09	-0.08	-0.08	-0.1
Capex to depreciation	-1.53	-1.81	-1.44	-1.45	-2.06
Stock based compensation to revenue	0	0	0	0	0
Graham number	551.4	2.64K	1.49K	2.67K	594.69
ROIC	-0.51	0.04	0.03	0.06	-0.03
Return on tangible assets	0	0.03	0.01	0.03	0
Graham Net	-1.84K	-2.01K	-1.88K	-2.01K	-2.02K
Working capital	61.36B	84.1B	81.52B	92.56B	96.63B
Tangible asset value	177.57B	178B	183.96B	192.84B	216.79B
Net current asset value	-86.7B	-99.82B	-89.59B	-81.31B	-68.35B
Invested capital	0.92	0.96	0.98	0.96	1.19
Average receivables	86.28B	89.5B	93.58B	97.64B	100.98B
Average payables	44.02B	42.2B	41.27B	43.88B	50.16B
Average inventory	74.05B	78.71B	78.47B	86.18B	108.98B
Days sales outstanding	92.79	100.38	101.42	98.62	91.68
Days payables outstanding	61.02	59.6	60.4	61.19	61.93
Days of inventory on hand	109.66	115.35	112.75	125.39	141.29
Receivables turnover	3.93	3.64	3.6	3.7	3.98
Payables turnover	5.98	6.12	6.04	5.96	5.89
Inventory turnover	3.33	3.16	3.24	2.91	2.58
ROE	0	0.08	0.02	0.07	0
Capex per share	-273.02	-347.52	-309.51	-327.56	-440.55

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	1.1K	1.14K	1.1K	1.16K	1.22K
Net income per share	-13.61	-117.33	-5.77	28.6	-4.97
Operating cash flow per share	108.29	104.1	102.49	110.83	115.03
Free cash flow per share	108.29	104.1	102.49	110.83	115.03
Cash per share	176.63	676.01	347.97	345.1	316.84
Book value per share	2.26K	2.14K	2.14K	2.16K	2.15K
Tangible book value per share	2.24K	2.44K	2.45K	2.52K	2.51K
Share holders equity per share	2.26K	2.14K	2.14K	2.16K	2.15K
Interest debt per share	2.18K	2.54K	2.47K	2.45K	2.6K
Market cap	88.89B	92.22B	90.69B	94.9B	93.12B
Enterprise value	267.01B	256.68B	277.22B	280.52B	294.01B
P/E ratio	-18.35	-2.21	-44.63	9.42	-53.15
Price to sales ratio	0.91	0.91	0.93	0.93	0.86
POCF ratio	9.22	9.98	10.05	9.72	9.19
PFCF ratio	9.22	9.98	10.05	9.72	9.19
P/B Ratio	0.44	0.49	0.48	0.5	0.49
PTB ratio	0.44	0.49	0.48	0.5	0.49
EV to sales	2.74	2.54	2.86	2.74	2.72
Enterprise value over EBITDA	513.47	-923.32	-1.22K	166.09	171.84
EV to operating cash flow	27.71	27.78	30.71	28.74	29.01
EV to free cash flow	27.71	27.78	30.71	28.74	29.01
Earnings yield	-0.01	-0.11	-0.01	0.03	0
Free cash flow yield	0.11	0.1	0.1	0.1	0.11
Debt to equity	0.96	1.19	1.15	1.13	1.21
Debt to assets	0.37	0.38	0.38	0.37	0.39
Net debt to EBITDA	342.53	-591.59	-821.72	109.9	117.41
Current ratio	1.59	1.48	1.4	1.47	1.47
Interest coverage	4.98	1.52	-0.28	7.32	7.45
Income quality	-7.96	-0.89	-17.77	3.88	-23.14
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0.02	0	0	0
Research and developement to revenue	0.04	0.03	0.04	0.04	0.04
Intangibles to total assets	0.01	0.01	0.01	0.01	0.01
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	832.6	2.37K	527.21	1.18K	489.94
ROIC	0.01	0	0	0	0
Return on tangible assets	0	-0.02	0	0	0
Graham Net	-2.15K	-2.03K	-2.06K	-2.25K	-2.38K
Working capital	89.45B	96.63B	78.22B	86.05B	84.05B
Tangible asset value	199.45B	216.79B	215.61B	217.29B	216.37B
Net current asset value	-84.62B	-68.35B	-77.75B	-87.7B	-99.18B
Invested capital	0.96	1.19	1.15	1.13	1.21
Average receivables	83.37B	83.91B	94.17B	91.57B	84.05B
Average payables	50.79B	51.18B	49.76B	47.54B	48.65B
Average inventory	117.48B	121.19B	123.53B	126.35B	126.28B
Days sales outstanding	72.82	79.01	92.27	73.54	70.45
Days payables outstanding	56.81	59.03	53.18	55.35	51.2
Days of inventory on hand	139.89	134.67	144.43	144.08	132.54
Receivables turnover	1.24	1.14	0.98	1.22	1.28
Payables turnover	1.58	1.52	1.69	1.63	1.76
Inventory turnover	0.64	0.67	0.62	0.62	0.68
ROE	-0.01	-0.05	0	0.01	0
Capex per share	0	0	0	0	0

3101.T Dividend History

3101.T Frequently Asked Questions

What is Toyobo Co., Ltd. stock symbol ?

Toyobo Co., Ltd. is a JP stock and trading under the symbol 3101.T

What is Toyobo Co., Ltd. stock quote today ?

Toyobo Co., Ltd. stock price is $1093 today.

Is Toyobo Co., Ltd. stock public?

Yes, Toyobo Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 339.34K
Market Capitalization 100.52B
Employee 10.89K
CEO Mr. Ikuo Takeuchi
Headquarters Osaka,JP
IPO Date 2000-01-04
Website https://www.toyobo-global.com

Toyobo Co., Ltd. provides films and functional polymers, industrial materials, and healthcare and textile products worldwide. It offers industrial films, including PET films for liquid crystal display, optical, and other industrial use; and synthetic papers. The company also provides packaging films, such as PET, polyolefin, and nylon for food packaging, as well as heat-shrink PET films; functional polymers comprising engineering plastics, industrial adhesives, coatings, photo-sensitive printing plates, acrylate polymers, and electronic materials; rubber and coat processing; and pharmaceuticals intermediates. In addition, it offers functional fibers consisting of airbag fabrics; polyethylene and PBO fibers; functional filters for automobiles, indoor, and anti-pollution solvent adsorption materials and units; and fiber materials for automobile parts. Further, the company provides bio products, including enzymes for diagnostics, diagnostic systems, and reagents for research; artificial kidney hollow fibers; anti-clotting materials; seawater desalination modules; functional textiles for sports clothing, underwear, and uniforms; synthetic filaments; apparel under the Munsingwear brand; acrylic fibers under the Exlan brand; and acrylate fibers under the eks brand, as well as trades in textile products. Additionally, it operates as a contract manufacturer of injections. The company was founded in 1882 and is headquartered in Osaka, Japan.